Organization | Statens Serum Institut

Statens Serum Institut Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Founded: Copenhagen Denmark (1902)

Organization Overview

First Clinical Trial

1989

NCT01353807

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2022

Timeline

NOW

Now

Alternative names

Bandim Health Project, Statens Serum Institut, Artillerivej 5, 2300 Copenhagen S, Denmark | Department of Epidemiology Research, Statens Serum Institut, 2300 Copenhagen S, Denmark | Research Center for Vitamins and Vaccines, Statens Serum Institute | Statens Serum Institut | Statens Serum Institut Denmark | Statens Serum Institute, Research Center for Vitamins and Vaccines, Bandim Health Project | Statens serum Institute/SSI/,Denamrk

Active Ingredients

Drugs in Phase 4 Trials (14)

23-valent pneumococcal polysaccharide vaccine (pneumovax-23) (1 trial)

acellular pertussis vaccine (including diptheria and tetanus toxoids) (Tripedia) (3 trials)

attenuated measles vaccine - Edmonston strain (rubeovax) (1 trial)

autologous microbiome (1 trial)

azithromycin (zithromax) (2 trials)

bacille calmette-guerin (3 trials)

doxycycline (vibramycin) (2 trials)

inactivated influenza vaccine (1 trial)

live oral poliovirus type 1, 2 and 3 (Trivalent oral polio vaccine - Sabin) (1 trial)

metronidazole (flagyl) (2 trials)

pneumococcal 13-valent conjugate vaccine (prevnar 13) (1 trial)

rifaximin (xifaxan) (1 trial)

tetracycline (tetrex) (1 trial)

vitamin a (1 trial)

Drugs in Phase 3 Trials (7)

Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix) (1 trial)

esomeprazole (nexium) (1 trial)

Inactivated polio virus - Enhanced (IPOL) (6 trials)

Tetanus and diphtheria toxoids adsorbed (Decavac) (1 trial)

Tuberculin, Purified Protein Derivative (Tubersol) (5 trials)

zinc dichloride (1 trial)

Drugs in Phase 2 Trials (7)

aeras-404 (4 trials)

aeras-456 (2 trials)

ic31 (6 trials)

polio, inactivated poliovirus vaccine (Salk Vaccine) (2 trials)

potassium alum (2 trials)

trichuris suis ova (1 trial)

Drugs in Phase 1 Trials (17)

adjuvanted tuberculosis subunit vaccine (1 trial)

afo-18 (2 trials)

ag85b (1 trial)

ag85b-esat-6 (2 trials)

ag85b-esat6 fusion protein h1 (1 trial)

caf01 (2 trials)

cth522 (2 trials)

dendritic cells pulsed with hiv antigens (1 trial)

esat-6 (1 trial)

etoricoxib (Gencox) (1 trial)

odn1a (1 trial)

r0.6c transmission blocking vaccine (1 trial)

rcfp-10 (2 trials)

rdesat-6 (2 trials)

sodium chloride (1 trial)

Drugs in Other Trials (16)

bifidobacterium animalis (2 trials)

bifidobacterium breve (1 trial)

bifidobacterium infantis (1 trial)

bifidobacterium longum (1 trial)

cefuroxime (zinacef) (1 trial)

ciprofloxacin (cipro) (1 trial)

fish oil (Omegavan) (1 trial)

Lactobacillus acidophilus (1 trial)

lactobacillus casei (1 trial)

lactobacillus delbrueckii (1 trial)

lactobacillus plantarum (1 trial)

lactobacillus rhamnosus (1 trial)

olive (2 trials)

praziquantel (biltricide) (1 trial)

streptococcus salivarius (1 trial)

vsl #3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Acquired Immunodeficiency Syndrome (Phase 1)

Ascites (Phase 4)

Chlamydia Infections (Phase 4)

Communicable Diseases (Phase 1)

Crohn Disease (Phase 4)

Diabetes, Gestational (Phase 4)

Diabetes Mellitus (Phase 3)

Diabetes Mellitus, Type 2 (Phase 3)

Dientamoebiasis (Phase 4)

Diphtheria (Phase 4)

Fibrosis (Phase 4)

HIV Infections (Phase 1)

Infant Death (Phase 4)

Infections (Phase 2)

Latent Tuberculosis (Phase 2)

Liver Cirrhosis (Phase 4)

Malaria (Phase 3)

Measles (Phase 4)

Multiple Sclerosis (Phase 2)

Mycoplasma Infections (Phase 4)

Pleuropneumonia (Phase 4)

Pneumonia (Phase 3)

Poliomyelitis (Phase 3)

Recurrence (Phase 2)

Sclerosis (Phase 2)

Tetanus (Phase 4)

Tetany (Phase 4)

Trachoma (Phase 1)

Tuberculosis (Phase 3)

Tuberculosis, Pulmonary (Phase 2)

Urethritis (Phase 4)

Uterine Cervicitis (Phase 4)

Whooping Cough (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 58
# of Trial APIs: 61